Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: DAX +0.29%, CAC40 +0.22%

May 04 ,2026

  • Synopsis

    • European equity markets set to open higher; note markets are closed today in Ireland and UK for a bank holiday. Asian equities mostly higher Monday with mainland China and Japan offline for Golden Week holiday. S&P 500 futures steady. Treasury cash market shut until London open. Dollar firming against yen and other majors. Crude little changed amid latest developments on US-Iran diplomatic front. Gold and silver weakening. Bitcoin gaining near one-week high.

    • Trump said US will guide stranded vessels through Strait of Hormuz, though this was met with skepticism with plan reportedly not involving US naval ships and Iranian threat/mines seen as ongoing deterrent absent a peace deal. Iran received US response to its latest offer, which mostly rehashed prior demands to reopen Strait of Hormuz, end blockade, reverse sanctions and remove US bases from region while leaving nuclear talks to later stage. Trump gave conflicting signals on response, telling Israeli media he didn't find it acceptable while later posting on Truth Social about very positive discussions that could lead to something positive.

    • On the agenda today in Europe, ECB publishes its latest survey of professional forecasters as well as aggregate result of its survey of monetary analysts at 10:00CET, the same time as first Economic Bulletin pre-release. Publication of the ECB Annual Report 2025 at 14:30CET. In macro releases today, Apr manufacturing PMI due for Italy, Sweden, Switzerland and final reads for Eurozone, followed by Eurozone May Sentix economic index.

    • Light in earnings releases. Overnight, UCB (UCB.BB) announced acquisition of Candid Therapeutics (+CANDID) at total transaction value of up to $2.2B. Further in M&A, ThyssenKrupp (TKA.GR) and Jindal International Steel (532286.IN) mutually agree to pause talks regarding a stake in thyssenkrupp Steel.

  • Politics/Macro/World News

    • Trump casts doubts on Iran peace proposal as details emerge - Bloomberg

    • German chancellor downplays row with Trump after troop drawdown announced -- Reuters

    • Trump says he is increasing tariffs on car and truck imports from the EU -- BBC

    • Trump says US navy will 'guide' trapped ships from strait of Hormuz amid 'very positive' talks with Iran -- The Guardian

    • Greece central bank's Stournaras says concerns about euro zone recession are real and justified amid energy shock - Phileleftheros

    • UK set to enter talks to join the European Union's $105.9 billion Ukraine loan -- Reuters

  • Top company news

    • Earnings/updates

      • STM.GR (Stabilus) -- final Q2 earnings: net income €9.3M vs year-ago €11.2M

      • RATO.B.SS (Ratos) -- Q1 EPS SEK0.67 vs FactSet SEK0.48 [5 est, SEK0.37-0.56]

      • MGNT.RU (Magnit) -- FY net income (RUB16.60B) vs year-ago RUB50.00B

      • ASA.NO (Atlantic Sapphire) -- Q1 EPS ($5.33) vs year-ago ($17.19

      • BNOR.NO (BlueNord) -- Q1 pretax income ($1.8M) vs year-ago ($2.3M); prelim Apr production of 43.6 mboepd net vs prior 42.5 mboepd

    • M&A

      • UCB.BB (UCB) -- to acquire Candid Therapeutics at total transaction value of up to $2.2B

      • DEC.LN (Diversified Energy) -- discloses completion of purchase and sale transaction with Sheridan Holding Company III, LLC - 8-K

      • SPEC.LN (Inspecs Group) -- Bidco 1125 announces offer for Inspecs Group will close for acceptance at 18:00BST on 15-May

      • TKA.GR (ThyssenKrupp) -- and Jindal International Steel have mutually agreed to pause talks regarding a stake in Steel

      • BRKN.SW (Burkhalter Holding) -- acquires Progressio Holding GmbH (parent company of anplaq ag); consideration ~38K new registered shares

      • NIL.B.SS (Nilörngruppen) --- receives SEK77/sh cash offer from Trimco; board recommends acceptance

    • Healthcare

      • NOVN.SW (Novartis) -- receives Health Canada approval for Fabhalta oral treatment for adults with C3G

      • GSK.LN (GSK Plc) -- FDA approves Arexvy sBLA for prefilled syringe

      • EVT.GR (Evotec) -- announces nomination of small molecule preclinical development candidate from its multi‑target drug discovery alliance in medical dermatology with Almirall S.A. (ALM.SM)

      • MOLN.SW (Molecular Partners) -- to present new data on MP0712 at forthcoming scientific conferences

      • DRW3.GR (Drägerwerk) -- sees EU as its biggest current problem as planned restrictions on "forever chemicals" could threaten core aspects of industrial and medical production - Handelsblatt

    • Other

      • ENGI.FP (ENGIE) -- to partner with Deep Sky to advance direct air capture

      • CPI.LN (Capita) -- reported to information commissioner by Cabinet Office over data breach in civil service pension scheme - London Times

      • EQT.SS (EQT) -- retains Danske Bank, Goldman Sachs, and Morgan Stanley to advise on options for WS Audiology, including potential Denmark IPO -- Bloomberg

      • GRKP.SW (Graubeundner Kantonalbank) -- notes lawsuit against subsidiary, BZ Bank Aktiengesellschaft, former and current members of BZ Bank Aktiengesellschaft's governing bodies, and against GKB itself (

      • France Apr new passenger car registration (0.3%) y/y to 138,339 vehicles -- PFA

      • IFS preparing for IPO within next two years; will consider London, Europe and New York for listing - FT, citing CEO

  • Key rating changes

    • Upgrades

      • CAMX.SS (Camurus) -- to buy from hold at Handelsbanken

      • CTPNV.NA (CTP NV) -- to buy from hold at Kepler Cheuvreux

      • LSG.NO (Lerøy Seafood Group) -- to buy from hold at Pareto

      • NHY.NO (Norsk Hydro) -- to buy from hold at Pareto

      • UMI.BB (Umicore) -- to buy from hold at Kepler Cheuvreux

    • Downgrades

      • JEN.GR (Jenoptik) -- to neutral from outperform at Oddo

  • Data

    • Nikkei closed

    • Hang Seng +1.49% to 26160.59

    • Shanghai Composite +0.00% to 4112.16

    • S&P futures +13.5 vs prior close of 7258.0

    • €-$ (0.0013) or (0.11%) to 1.1733

    • $-¥ (0.03) or (0.02%) to 156.76

    • €-¥ (0.31) or (0.17%) to 183.88

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.